Precision Thrombectomy Powered by Physics
FlowPhysix was founded to set new standards for endovascular thrombectomy. In peripheral applications, significant performance gaps persist with current systems, and physicians continue to seek better solutions. By leveraging the foundational science of fluid dynamics and extensive studies of clot morphology, the company developed the FLOWRUNNER™ Aspiration System: a compact, valve-controlled catheter engineered to outperform devices twice its size by preventing vacuum decay and maintaining consistent aspiration force throughout the procedure.
A breakthrough technology for thrombectomy
The FLOWRUNNER Aspiration System by FlowPhysix is the first aspiration system designed to safely and effectively remove clots while minimizing vascular damage and enabling control over blood loss throughout the procedure.
On a clear path to success
After achieving 510(k) FDA clearance and performing our first-in-human cases, FlowPhysix is now commercializing the FLOWRUNNER Aspiration System.
- FlowPhysix was incubated in 2022
- Spun off from Expanse Medical in April 2024
- Now commercializing in the US and in select global geographies